Sanex Pharmaceuticals Limited
About Sanex Pharmaceuticals Limited
Data last updated:
Sanex Pharmaceuticals Limited is a public limited company based in Kolkata, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 July 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24232WB2006PLC110613.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9.98 Lakh. It is led by directors including Raj Kumar Todi and Dhruv Todi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 12 Darga Road Ground Floor Kol – 700017, Kolkata, West Bengal, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹83,905, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹47,834 (net margin 57%) and EBITDA of ₹66,271 (EBITDA margin 79%). Revenue has grown at a compounded annual rate (CAGR) of 48% over three years and 22% over five years.
Court records list 2 cases involving the company, including 2 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sanex Pharmaceuticals Limited's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address12 Darga Road Ground Floor Kol – 700017, Kolkata, West Bengal, India
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sanex Pharmaceuticals Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Sanex Pharmaceuticals Limited
FY 2025 filings availableSanex Pharmaceuticals Limited reported revenue of ₹83,905 (up 228% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 22% over five years, including 228% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹66,271 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹47,834 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 79% | ||||
| Net Profit Margin | 57% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sanex Pharmaceuticals Limited, buy the company report.
Board of directors of Sanex Pharmaceuticals Limited
Sanex Pharmaceuticals has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raj Kumar Todi | Director | 14 Jul 2006 | 20 Years 3 Months | Current |
| Dhruv Todi | Director | 10 Oct 2006 | 20 Years 0 Months | Current |
| Sangita Todi Also directs: R. K. Fuels Private Limited, Sarvamanngal Distributors Pvt Ltd, Mukund Intra Pvt Ltd and 1 more | Director | 13 Sep 2010 | 16 Years 1 Months | Current |
Auditor
Sanex Pharmaceuticals Limited is audited by Maheswari K R & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Maheswari K R & Co | FY 2023 | 323732E |
Shareholding
The shareholding of Sanex Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sanex Pharmaceuticals Limited, buy the company report.
Legal cases
Sanex Pharmaceuticals Limited has 2 court cases on record: 2 filed by Sanex Pharmaceuticals. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLT | 2 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Kolkata | Court case (C.P.(CAA)) | Filed by the company | Disposed |
| NCLT, Kolkata | Court case (C.A.(CAA)) | Filed by the company | Disposed |
To see the full case history of Sanex Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sanex Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sanex Pharmaceuticals Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sanex Pharmaceuticals Limited has 6 board changes on record since 2006: 3 appointments and 3 cessations. The latest: Sangita Todi ceased to be Additional Director on 30 Sep 2010.
Frequently asked questions
Sanex Pharmaceuticals is an active public limited company based in Kolkata, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 July 2006 (20+ years old) and is registered under CIN U24232WB2006PLC110613.
Sanex Pharmaceuticals has 3 current directors:
- Raj Kumar Todi - Director
- Dhruv Todi - Director
- Sangita Todi - Director
The latest financial statements of Sanex Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Sanex Pharmaceuticals is U24232WB2006PLC110613. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sanex Pharmaceuticals has 2 court cases on record: 2 filed by the company.
Sanex Pharmaceuticals was incorporated on 14 July 2006, making it 20+ years old. It is registered with the Registrar of Companies, Kolkata.
Sangita Todi ceased to be Additional Director on 30 Sep 2010. Rishi Todi ceased to be Director on 13 Sep 2010. Sangita Todi was appointed as Director on 13 Sep 2010. Sanex Pharmaceuticals has 6 board changes on record in total.
The registered office of Sanex Pharmaceuticals is at 12 Darga Road Ground Floor Kol – 700017, Kolkata, West Bengal, India.
Sanex Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Sanex Pharmaceuticals is compliant as of 02 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
